跳至主要内容
临床试验/ACTRN12616000923460
ACTRN12616000923460终止未知

A Prospective Observational Study Assessing The Role of IL-6 On The Platelet Protective Effects of Paclitaxel-based Chemotherapy in Patients with Epithelial Ovarian Cancer

Icon Cancer Foundation0 个研究点目标入组 6 人开始时间: 2016年7月12日最近更新:
适应症

试验速览

阶段
未知
状态
终止
入组人数
6

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Female

入选标准

  • Women with histologically confirmed epithelial ovarian cancer.
  • Patients considered for neoadjuvant chemotherapy at the participating centres (i.e. planned for carboplatin and paclitaxel first-line neo-adjuvant chemotherapy at the Icon Cancer Care, Johns Hopkins and MD Anderson and Gustave Roussy Gynaecological Oncology clinics)
  • Age greater than or equal to 18 years
  • WHO performance status of 0, 1 or 2

排除标准

  • Unresolved bowel obstruction
  • Previous lines of chemotherapy
  • Radiotherapy within the preceding 3 weeks
  • Treatment with any investigational agent within the preceding 4 weeks or within 5 half-lives of the investigational agent, whichever is longer.
  • Known leptomeningeal involvement or intracranial disease
  • Pregnant or lactating females.
  • Inability or unwillingness to give informed consent.

研究者

相似试验